Oral Brepocitinib

DRUG2 trials

Sponsors

Priovant Therapeutics, Inc.

Conditions

Cutaneous SarcoidosisLichen Planopilaris

Phase 2

A Study of Brepocitinib in Adults With Cutaneous Sarcoidosis

RecruitingNCT06978725

Priovant Therapeutics, Inc.Cutaneous Sarcoidosis

Start: 2025-04-09End: 2029-12-31Target: 168Updated: 2026-08-27

A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris

RecruitingNCT07532603

Priovant Therapeutics, Inc.Lichen Planopilaris

Start: 2026-03-19End: 2029-07-31Target: 342Updated: 2026-07-08